Did anyone here participate in this trial?
http://www.thepharmaletter.com/file/114889/merck-co-closes-odanacatib-trial -early-on-good-results-in-osteoporosis.html
US drug giant Merck & Co (NYSE: MRK) says it is halting a Phase III trial of its investigational osteoporosis drug odanacatib early on the recommendation of the independent Data Monitoring Committee due to robust efficacy and a favorable benefit-risk profile.
Also see http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951121



Thanks for the post......very interesting! As with any new drug coming on the market, caution is advised. Long term side effects???